INTERFERON ALPHA-2A IN THE TREATMENT OF THROMBOCYTOSIS IN MYELOPROLIFERATIVE SYNDROME

被引：0
|
作者：
TICHELLI, A [1 ]
GRATWOHL, A [1 ]
DELACRETAZ, F [1 ]
DAZZI, H [1 ]
STEBLER, C [1 ]
WERNLI, M [1 ]
HOLDENER, EE [1 ]
NISSEN, C [1 ]
SPECK, B [1 ]
机构：
[1] INST UNIV PATHOL,LAUSANNE,SWITZERLAND
来源：
SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT | 1989年 / 119卷 / 39期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1347 / 1352
页数：6
相关论文
共 50 条
  • [41] Pegylated interferon alpha-2a in high risk myeloproliferative neoplasms: A safe, effective and well tolerated alternative to hydroxycarbamide
    Garg, M.
    Ruparelia, M.
    Sachedina, S.
    Asagba, G.
    Krishna, R.
    Qureshi, H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 136 - 136
  • [42] Management of essential thrombocythemia during pregnancy with aspirin, interferon alpha-2a and no treatment
    Ventroyen, B
    Vanstraelen, D
    ACTA HAEMATOLOGICA, 2002, 107 (03) : 158 - 169
  • [43] FOLLICULAR MYCOSIS-FUNGOIDES - RESPONSE TO TREATMENT WITH INTERFERON ALPHA-2A AND ETRETINATE
    SALLERAS, M
    TORNE, R
    LOPEZGIL, F
    SANCHEZREGANA, M
    UMBERT, P
    EUROPEAN JOURNAL OF DERMATOLOGY, 1995, 5 (06) : 497 - 500
  • [44] Treatment of chronic hepatitis C infection with interferon alpha-2a in a Turkish population
    Simsek, H
    Tatar, G
    Savas, C
    Telatar, H
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1996, 24 (01) : 132 - 137
  • [45] Nanomedicines in the treatment of chronic hepatitis C - focus on pegylated interferon alpha-2a
    Thomas, Thea
    Foster, Graham
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2007, 2 (01): : 19 - 24
  • [46] INTERFERON ALPHA-2A IN THE TREATMENT OF RECURRENT SUBFOVEAL NEOVASCULARIZATION FOLLOWING SURGICAL REMOVAL
    THOMAS, MA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1992, 33 (04) : 725 - 725
  • [47] Pegylated interferon alpha-2a is clinically effective and tolerable in myeloproliferative neoplasm patients treated off clinical trial
    Gowina, K.
    Jain, T.
    Kosiorek, H.
    Tibes, R.
    Camoriano, J.
    Palmer, J.
    Mesa, R.
    LEUKEMIA RESEARCH, 2017, 54 : 73 - 77
  • [48] Pegylated interferon alpha-2a (40 kDa) in the treatment of chronic hepatitis B
    Lai, Lawrence
    Hui, Chee-Kin
    Leung, Nancy
    Lau, George K.
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2006, 1 (03): : 255 - 262
  • [49] ADAMANTIADES-BEHCET DISEASE - TREATMENT WITH SYSTEMIC RECOMBINANT INTERFERON ALPHA-2A
    ZOUBOULIS, CC
    TREUDLER, R
    ORFANOS, CE
    HAUTARZT, 1993, 44 (07): : 440 - 445
  • [50] USE OF RECOMBINANT INTERFERON ALPHA-2A IN THE TREATMENT OF SQUAMOUS-CELL CARCINOMA
    CHIMENTI, S
    COTELLESSA, C
    PERIS, K
    DICRISTOFARO, S
    FARGNOLI, MC
    TORLONE, G
    JOURNAL OF DERMATOLOGICAL TREATMENT, 1995, 6 (03) : 163 - 166
12345